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The latency-associated transcript (LAT) is the only abundant herpes simplex virus type 1 (HSV-1) transcript
expressed during latency. In the rabbit eye model, LAT null mutants do not reactivate efficiently from latency.
We recently demonstrated that the LAT null mutant dLAT2903 induces increased levels of apoptosis in
trigeminal ganglia of infected rabbits compared to LAT1 strains (G.-C. Perng, C. Jones, J. Ciacci-Zarella, M.
Stone, G. Henderson, A. Yokht, S. M. Slanina, F. M. Hoffman, H. Ghiasi, A. B. Nesburn, and C. S. Wechsler,
Science 287:1500–1503, 2000).The same study also demonstrated that a plasmid expressing LAT nucleotides
301 to 2659 enhanced cell survival of transfected cells after induction of apoptosis. Consequently, we hypoth-
esized that LAT enhances spontaneous reactivation in part, because it promotes survival of infected neurons.
Here we report on the ability of plasmids expressing different portions of the 5* end of LAT to promote cell
survival after induction of apoptosis. A plasmid expressing the first 1.5 kb of LAT (LAT nucleotides 1 to 1499)
promoted cell survival in neuro-2A (mouse neuronal) and CV-1 (monkey fibroblast) cells. A plasmid expressing
just the first 811 nucleotides of LAT promoted cell survival less efficiently. Plasmids expressing the first 661
nucleotides or less of LAT did not promote cell survival. We previously showed that a mutant expressing just
the first 1.5 kb of LAT has wild-type spontaneous reactivation in rabbits, and a mutant expressing just the first
811 nucleotides of LAT has a reactivation frequency higher than that of dLAT2903 but lower than that of
wild-type virus. In addition, mutants reported here for the first time, expressing just the first 661 or 76
nucleotides of LAT, had spontaneous reactivation indistinguishable from that of the LAT null mutant
dLAT2903. In summary, these studies provide evidence that there is a functional relationship between the
ability of LAT to promote cell survival and its ability to enhance spontaneous reactivation.
Following ocular, oral, or intranasal infection, herpes sim-
plex virus type 1 (HSV-1) establishes latent infection in tri-
geminal ganglia (TG) (3, 4). The only abundant viral transcript
expressed in latently infected neurons is the latency-associated
transcript (LAT) (11, 12, 32, 48, 51, 54). The primary 8.3-kb
primary LAT transcript is unstable and is spliced, yielding an
abundant stable 2-kb LAT (12, 48, 53, 56) that is a stable intron
(17, 33). LAT is antisense to ICP0 and is primarily localized in
the nucleus. This has led to the suggestion that LAT represses
ICP0 expression by an antisense mechanism (48), which in turn
represses productive infection (8, 20). However, we previously
showed that the first 1.5 kb of the primary LAT is sufficient for
spontaneous reactivation from latency (45). Since this region
does not overlap ICP0, antisense repression of ICP0 expres-
sion by LAT is not required for spontaneous reactivation in the
rabbit model. Although LAT is important for latency in small-
animal models (27, 52), its functional roles during the latency-
reactivation cycle are not understood.
In transient—transfection assays, a LAT fragment (LAT
nucleotides 301 to 2659) encompassing the stable 2-kb LAT
derived from strain KOS enhanced cell survival following an
apoptotic insult (42). The same study also demonstrated that a
McKrae LAT2 mutant (dLAT2903) had increased levels of
apoptosis in rabbit TG. These findings suggested that LAT is
important for latent infections because it promotes survival of
infected neurons.
HSV-1 can induce or inhibit apoptosis (programmed cell
death) in a cell type-dependent manner after infection of cul-
tured cells (1, 2, 18, 19, 36). Several antiapoptotic genes have
been identified (1, 2, 18, 42), suggesting that regulation of
apoptosis is crucial for the virus’s life cycle. Trauma, stress, or
other imbalances of growth factors or cytokines can induce
neuronal apoptosis, and neuronal apoptosis is linked to neu-
rodegenerative disorders (7, 21, 23, 26, 35, 38–40). HSV-1
replication and productive gene expression can occur in sen-
sory ganglia during acute infection and reactivation from la-
tency (29–31, 50), which can lead to apoptosis in TG during
acute infection (42). Thus, the ability of HSV-1 to minimize
neuronal apoptosis may be an important aspect of the latency
cycle.
In this study, we demonstrate that pLAT3.3, a plasmid ex-
pressing the first 1.5 kb of the 8.3-kb primary HSV-1 McKrae
LAT, promotes cellular survival in CV-1 and neuro-2A cells
following apoptosis induction. This region does not overlap
ICP0 and contains only 838 nucleotides of the 59 end of the
stable 2-kb LAT intron. We also demonstrate that pLAT3.3
inhibited Bax-induced apoptosis in CV-1 cells. Additional plas-
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mids expressing smaller regions of LAT were constructed and
tested. The ability of these plasmids to promote cell survival
correlated with the ability of recombinant viruses expressing
the corresponding LAT fragments to spontaneously reactivate
in the ocular rabbit model of HSV-1 latency. This suggests that
the ability of LAT to promote cell survival after induction of
apoptosis plays an important role at one or more steps in the
HSV-1 latency cycle.
MATERIALS AND METHODS
Cells and viruses. Cells were plated at a density of 5 3 105 cells/100-mm plastic
dish in Earl’s modified Eagle’s medium supplemented with 5% fetal bovine
serum. All medium contained penicillin (10 U/ml) and streptomycin (100 mg/ml).
CV-1 cells were split at a 1:5 ratio every 4 or 5 days. Neuro-2A cells were
obtained from the American Type Culture Collection (Rockville, Md.) and split
in a 1:4 ratio every 3 to 5 days.
All parental and mutant viruses were plaque purified three times and passaged
only one or two times prior to use. Wild-type McKrae, dLAT2903, dLAT2903R,
LAT3.3A (originally designated LAT1.5a), and LAT2.6A have been described
previously (16, 44, 45). Rabbit skin (RS) cells, used for preparation of virus
stocks and for culturing rabbit tear films, were grown in Eagle’s minimal essential
medium supplemented with 5% fetal calf serum (FCS).
Bluo-gal cotransfection and analysis of cell death. Cells were plated at a
density of 2 3 105/well in six-well plastic plates (35 mm2/well) 12 to 16 h prior to
the transfection. Cells were transfected with a human cytomegalovirus (CMV)
expression vector containing the b-galactosidase gene (pCMV–b-Gal) and one
of the plasmids described below by the calcium phosphate method. For each
35-mm well, 250 ml of a calcium phosphate solution (125 mM CaCl2, 25 mM
HEPES-NaOH [pH 7.1], 0.75 mM Na2HPO4-NaH2PO4 [pH 7.0], 125 mM NaCl)
and the designated amount of plasmid DNA mixture were added to the cells.
Five hours after transfection, cells were shocked with 20% glycerol–phosphate-
buffered saline (PBS) solution for 4 min and then washed with PBS twice. Fresh
medium containing 5% FCS and 5 mM sodium butyrate was added to the cells
to enhance expression of genes encoded by plasmids, because sodium butyrate
can inhibit histone deacetylase activity (5). Long-term treatment of cell lines with
sodium butyrate can lead to apoptosis (22, 49). When CV-1 cells are treated with
5 mM sodium butyrate for 16 h, we have seen an approximately twofold increase
in apoptosis, as judged by measuring ONA content (data not shown). When
CV-1 cells are treated for 40 to 48 h with sodium butyrate, we can routinely
detect 7 to 12 times more apoptosis than in control cultures. The cells from each
well were incubated at 37°C for 16 h and then subcultured at a 1:5 ratio onto a
24-well dish. These cells were treated with 15 mM etoposide or 5 mM sodium
butyrate (37°C for 48 h), and b-galactosidase expression was analyzed as de-
scribed previously (9, 10, 25, 42). Briefly, cells were rinsed with calcium- and
magnesium-free PBS (CMF-PBS), fixed with 2% formaldehyde–0.2% glutaral-
dehyde in PBS for 5 min, and then washed twice with CMF-PBS. Fixed cells were
stained for 6 to 24 h with 0.1% Bluo-gal (Gibco) in a PBS solution which
contained 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, and 2
mM MgCl2. After rinsing in PBS, positive cells were observed microscopically,
and the average number of blue-stained cells was counted. At least five fields per
plate were counted, and the average number of cells per field was calculated.
The Bax expression plasmid used in this study was purchased from Upstate
Biotechnology (Lake Placid, N.Y.). The Bcl-2 expression plasmid was obtained
from John Reed (San Diego, Calif.).
Construction of LAT2.5A and LAT1.8A. LAT1.8A contains the LAT promoter
plus the first 76 nucleotides of the primary LAT RNA in the unique long region
between UL37 and UL38. LAT2.5A contains the LAT promoter and the first 661
nucleotides of the primary LAT RNA in the same novel location. The parental
virus for both constructs was dLAT2903, a mutant of HSV-1 strain McKrae
containing a 1.8-kb (EcoRV-HpaI) deletion in both copies of LAT that removed
0.2 kb of the LAT promoter and 1.6 kb of the 59 end of the primary 8.3-kb LAT
transcript (44). dLAT2903 transcribes no LAT RNA and reactivates poorly
relative to LAT1 viruses (wild type or dLAT2903R). These mutants were con-
structed as previously described for LAT3.3A (originally designated LAT1.5a)
and LAT2.6A (16, 43, 44, 46) except for the size of the structural portion of the
LAT gene included with the LAT promoter (shown schematically in Fig. 5).
Briefly, an HSV-1 McKrae restriction fragment containing LAT nucleotides
21793 to 176 (the LAT promoter plus the first 76 nucleotides of the primary
LAT) or LAT nucleotides 21793 to 1661 (the LAT promoter plus the first 661
nucleotides of the primary LAT) was inserted into a uniquely constructed PacI
site between the HSV-1 McKrae genes UL37 and UL38 contained in plasmid
pV375Pac (45). LAT1.8A and LAT2.5A were each generated by cotransfection
and homologous recombination of infectious dLAT2903 viral DNA with the
LAT1.8A or LAT2.5A plasmid as we previously described (45). Following co-
transfection, isolated plaques were picked and screened for the proper insertion
between UL37 and UL38 by restriction digestion and Southern analysis. Selected
plaques were plaque purified three times and grown into virus stocks. Virus
stocks were analyzed by restriction enzyme digestion and Southern blots to
confirm that the correct LAT fragment was present between UL37 and UL38.
This analysis also verified that both long repeats retained the original deletion
(the 1.8-kb LAT promoter and the first 1.6 kb of the 59 end of the primary LAT
transcript) in both viral long repeats.
Rabbits. New Zealand White male rabbits (Irish Farms), 8 to 10 weeks old,
were used for all experiments. Rabbits were treated in accordance with the
Association for Research in Vision and Ophthalmology, American Association
for Laboratory Animal Care, and National Institutes of Health guidelines.
Rabbit model of ocular HSV-1 infection, latency, and spontaneous reactiva-
tion. Rabbits were bilaterally infected without scarification or anesthesia by
placing 2 3 105 PFU of HSV-1 per eye into the conjunctival cul-de-sac, closing
the eye, and rubbing the lid gently against the eye for 30 s (16, 42, 44, 45, 47). At
this dose of HSV-1 McKrae, virtually all of the surviving rabbits harbor a
bilateral latent HSV infection in both TG, resulting in a high group rate of
spontaneous reactivation. Latency is assumed to be established by 28 days postin-
fection. Acute ocular infection of all eyes was confirmed by HSV-1-positive tear
film cultures collected on day 3 or 4 postinfection.
Detection of spontaneous reactivation by ocular shedding. Beginning on day
30 postinfection, tear film specimens were collected daily from each eye for 26
days as previously described (16, 42, 44, 45, 47), using a nylon-tipped swab. The
swab was then placed in 0.5 ml of tissue culture medium and squeezed, and the
inoculated medium was used to infect RS cell monolayers. These monolayers
were observed in a masked fashion by phase light microscopy for up to 7 days for
HSV-1 cytopathic effects (CPE). All positive monolayers were blind passaged
onto fresh cells to confirm the presence of virus. Viral DNA was purified from
randomly selected positive cultures derived from latently infected rabbits and
analyzed by restriction enzyme digestion and Southern blots to confirm that the
CPE was due to reactivated HSV-1 and that the reactivated virus was identical
to the input virus.
Statistical analyses were performed using Instat, a personal computer software
program. Results were considered statistically significant when the P value was
,0.05.
RESULTS
Localization of McKrae LAT sequences that promote cell
survival. Our previous study demonstrated that in transient-
transfection assays, a plasmid expressing LAT nucleotides 301
to 2659 from HSV-1 KOS promoted cell survival after induc-
tion of apoptosis and that the HSV-1 McKrae LAT reduces
apoptosis frequency in TG of infected rabbits (42). To confirm
that McKrae LAT would also promote cell survival after apo-
ptosis induction in cultured cells and to further map the in-
volved LAT region, LAT plasmids were constructed from
McKrae (Fig. 1). These plasmids contain the LAT promoter
but do not possess a strong exogenous poly (A) addition site at
their 39 terminus, suggesting that transcripts synthesized from
these constructs would not have polyadenylated tails. The abil-
ity of LAT fragments to inhibit apoptosis was measured by
cotransfecting cells with a b-Gal expression plasmid (pCMV–
b-Gal) and the designated LAT constructs (9, 10, 25, 34, 42).
Apoptosis was then induced by treating the cultures with 5 mM
sodium butyrate or 15 mM etoposide. Both chemicals induce
apoptosis in a variety of cells (5, 6, 22, 37, 49). Monkey kidney
(CV-1) or mouse neuroblastoma (neuro-2A) cells that are
transfected with pCMV–b-Gal have fewer blue cells when apo-
ptosis is induced (9, 10, 47). If the LAT plasmid inhibits apo-
ptosis, the number of b-Gal1 cells will be higher than in the
empty vector control.
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We have previously characterized the effects that several
chemicals have on apoptosis using CV-1 cells (9, 10, 42) and
have shown that the APALAT fragment (Fig. 1) protects CV-1
and neuro-2A cells from apoptosis (42). Since the latency
model used for McKrae is the rabbit, rabbit skin cells could
have been used to examine apoptosis. However, we thought
that for the purposes of mapping the region within LAT that
protects against apoptosis, it was logical to employ the cells we
used previously. In addition, CV-1 cells efficiently support
HSV-1 productive infection and LAT transcription. Neuro-2A
cells retain many neuronal characteristics, and there are no
available neuron-like cell lines derived from rabbits.
Following treatment with etoposide or sodium butyrate,
APALAT (KOS nucleotides 301 to 2659) and the antiapo-
ptotic baculovirus gene cpIAP both had a higher frequency of
cell survival than a blank expression vector (pcDNA3.1) (Fig.
2). Neuro-2A cells transfected with pLAT3.3 also had in-
creased cell survival relative to cells transfected with
pcDNA3.1 following treatment with sodium butyrate or eto-
poside. pLAT3.3 also enhanced cell survival in CV-1 cells
treated with sodium butyrate. In both cases, the increased
survival with pLAT3.3 was similar to that seen with APALAT.
This confirms that McKrae LAT and KOS LAT can both
enhance cell survival after apoptosis induction with similar
efficiency. Furthermore, it suggests that the cell survival do-
main resides in the region common to both plasmids, which is
bounded by LAT nucleotides 301 to 1499.
Etoposide did not consistently induce apoptosis in CV-1
cells and thus was not used for this study. Cultures of CV-1 and
neuro-2A cells transfected with pLAT2.5, pLAT2.4, or
pLAT1.8, had levels of cell survival similar to those in cultures
transfected with pcDNA3.1 after apoptosis induction. This
suggested that expression of LAT nucleotides 1 to 661
(pLAT2.5) or less (pLAT2.4 and pLAT1.8) was unable to
protect cells from apoptosis. As expected, the promoterless
FIG. 1. Schematic representation of plasmid inserts tested for antiapoptosis activity in transient-transfection assays. LAT, shown at the top,
indicates the relative location of the LAT promoter, the primary 8.3-kb LAT RNA, and the stable 2-kb LAT intron (black box). The region
downstream of the 2-kb LAT contains a break and is not drawn to scale. APALAT contains the Moloney murine leukemia virus (MoMLV) long
terminal repeat (LTR) driving expression of LAT (nucleotides 301 to 2659) from HSV-1 strain KOS. The remaining LAT fragments are all derived
from HSV-1 strain McKrae. The portion of the LAT promoter in pEV (2161 to 176) is sufficient for high transcription levels in transient-
transfection assays. pEV(pro2) is identical to pEV but without the promoter. The LAT fragments in pLAT3.3, pLAT2.6, pLAT2.5, and pLAT1.8
correspond to the UL37-UL38 LAT inserts in the LAT3.3A, LAT2.6A, LAT2.5A, and LAT1.8A mutant viruses shown in Fig. 5, respectively.
FIG. 2. Efficiency of cell survival after transfection with LAT con-
structs. Deletion plasmids of LAT are shown in Fig. 1. CV-1 and
neuro-2A (2A) cells were transfected with LAT constructs (4 mg of
DNA) and pCMV–b-Gal (1 mg of DNA). Cells were treated with
sodium butyrate (Na-But, 5 mM) or etoposide (Etop, 15 mM) to
induce apoptosis. Cell survival was measured by counting b-Gal1 cells
at 48 h after transfection as described previously (9, 10, 42). The
number of b-Gal1 cells that were present in cultures transfected with
pCMV–b-Gal plus pcDNA3.1 without etoposide or sodium butyrate
treatment was set at 100%. The values are the means of five different
experiments.
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LAT fragment pLAT1.0 also was not able to promote cell
survival.
Interestingly, pLAT2.6, expressing LAT nucleotides 1 to
811, had cell survival values that were lower than those for
pLAT3.3 and APALAT but slightly higher than those for the
other deletion constructs or the empty plasmid. This suggested
that LAT nucleotides 1 to 811 retained a small amount of
activity but that additional sequences were required for effi-
cient cell survival, as seen with the larger LAT plasmids (i.e.,
LAT nucleotides 1 to 1499 or 301 to 2659). CV-1 and neuro-2A
cells transfected with pEV, a construct containing the first 1.5
kb of LAT and the minimal LAT promoter, also exhibited
enhanced cell survival relative to those transfected with
pcDNA3.1. The enhanced cell survival was similar to that of
both pLAT3.3 and APALAT, consistent with this promoter
having high activity in these cells (56). When the promoter was
deleted [pEV(pro2)], cell survival was not enhanced, demon-
strating that expression of LAT was necessary for its cell sur-
vival activity.
Although the data in Fig. 2 suggested that LAT products
inhibited apoptosis in transiently transfected cells, one could
argue that LAT transactivated the CMV immediate-early pro-
moter in the CMV–b-Gal plasmid and that this resulted in
increased numbers of b-Gal1 cells. To eliminate this possibil-
ity, the pEV construct was cotransfected with a CMV-chlor-
amphenicol acetyltransferase (CAT) construct, and CAT ac-
tivity levels were measured. In three independent experiments,
pEV did not activate the CMV promoter (Fig. 3A). The in-
tensity of the blue cells and the number of blue cells were
similar when LAT (pEV) or a blank expression vector
(pNEB193) (Fig. 3B) was cotransfected with pCMV–b-Gal,
which was consistent with the inability of pEV to transactivate
the CMV promoter. After etoposide treatment, the number of
b-Gal1 cells decreased less when CV-1 cells were cotrans-
fected with pEV in addition to pCMV–b-Gal. Since etoposide
induces apoptosis in a variety of mammalian cells (5, 22, 49), a
reduction in b-Gal1 cells after etoposide treatment is indica-
tive of apoptosis, as we concluded previously (9, 10, 42).
LAT sequences inhibit Bax-induced apoptosis. Bax is an
important proapoptotic protein that interacts with the mito-
chondrial membrane, promotes cytochrome c release, and thus
activates Apaf-1 (apoptosis-activating factor-1) (41, 55). Acti-
vated Apaf-1 initiates a caspase cascade that precedes the
cytological and biochemical events leading to apoptosis. The
Bcl-2 protein interacts with Bax and thus inhibits apoptosis. A
CMV expression vector containing Bax reduced the number of
b-Gal1 CV-1 cells (Fig. 4A) and neuro-2A cells (data not
shown). To determine if LAT could inhibit Bax-induced apo-
ptosis, cells were cotransfected with Bax, pEV, pEV(pro2)
and pCMV-b-Gal. A dose-dependent increase in b-Gal1 cells
was observed when increasing amounts of the pEV construct
were cotransfected with Bax. In contrast, the pEV (pro2)
construct had no effect on Bax-induced apoptosis, indicating
that expression of LAT was necessary for promoting cell sur-
vival. As expected, Bcl-2 interfered with Bax-induced apoptosis
and was more efficient than the pEV construct.
The b-Gal1 cells (blue cells) transfected with Bax were
compared to those cotransfected with Bax and APALAT or
Bax and pEV by specifically staining DNA with Hoescht 33342.
This procedure allows one to identify b-Gal1 cells using phase
contrast microscopy and then visualize chromatin by fluores-
cence. b-Gal1 cells transfected with Bax had condensed chro-
matin and more frequently contained apoptotic bodies (Fig.
4B) compared to cells transfected with the empty vector (Fig.
4C). In contrast, b-Gal1 cells from cultures cotransfected with
Bax plus APALAT (Fig. 4D) or Bax plus pEV (Fig. 4E) had
less condensed chromatin and had nuclear morphology similar
to that of normal cells. Of 200 b-Gal1 cells that were trans-
fected with Bax alone, 86% had condensed chromatin and thus
were apoptotic. Only 20% of the b-Gal1 cells transfected with
Bax and pEV or Bax and APALAT appeared to be apoptotic.
Thus, LAT (both pEV and APALAT) interfered with Bax-
induced apoptosis.
Lack of spontaneous reactivation by LAT1.8A and LAT2.5A.
To determine if the ability of LAT to interfere with apoptosis
correlated with spontaneous reactivation, additional LAT de-
letion mutants were constructed and tested in the rabbit ocular
latency model. The genomic structures of wild-type HSV-1
McKrae, dLAT2903, dLAT2903R, LAT3.3A, LAT2.6A,
LAT2.5A, and LAT1.8A are shown in Fig. 5. All viruses were
derived from HSV-1 strain McKrae. The construction and
properties of dLAT2903, its marker-rescued virus
dLAT2903R, LAT3.3A, and LAT2.6A have been described
previously (16, 44, 45). Wild-type McKrae contains two copies
of LAT, one in each viral long repeat. dLAT2903 contains a
deletion in both copies of LAT from 2161 to 11677 relative to
the start of the primary LAT transcript (Fig. 5B, indicated by
XXXXX). This virus is missing key promoter elements, makes
no LAT RNA, and is a true LAT null mutant. Insertion of 1.8
kb of the LAT promoter and different lengths of LAT into a
unique PacI site that was constructed between UL37 and UL38
(Fig. 5C, D, E, and F) gave LAT3.3A, LAT2.6A, LAT2.5A,
and LAT1.8A from dLAT2903. Due to the complete deletion
of the LAT promoter and the first 1.67 kb of the primary LAT
transcript, none of these mutants are capable of transcribing
any LAT RNA from either copy of LAT in the long repeats
(16). As previously shown for LAT3.3A and LAT2.6A (46, 47),
these mutants do, however, transcribe the expected region of
LAT from their ectopic insert. LAT3.3A, LAT2.6A, LAT2.5A,
and LAT1.8A make the first 1,499, 811, 661, and 76 nucleo-
tides of the primary LAT, respectively. Additional details of
the construction of these viruses are given in Materials and
Methods.
As with the LAT null mutant dLAT2903 (44), LAT1.8A and
LAT2.5A were wild type for replication in tissue culture, rep-
lication in rabbit eyes, induction of eye disease in rabbits, and
neurovirulence, as judged from rabbit survival (data not
shown). To examine spontaneous reactivation, 18 rabbits/
group were infected with 2 3 105 PFU of LAT1.8A,
dLAT2903, dLAT2903R, or LAT3.3A per eye. In a separate
experiment, 28 or 29 rabbits/group were similarly infected with
LAT2.5A, dLAT2903, or LAT3.3A. Beginning 30 days postin-
fection (at which time latency had already been established),
the eyes from all surviving rabbits were swabbed once a day for
26 days to collect tear films for analysis of reactivated virus as
described in Materials and Methods. The cumulative number
of virus-positive tear film cultures is shown in Fig. 6A and B.
Because there were minor, nonsignificant differences in the
numbers of surviving rabbits in the different groups within each
experiment, the data were standardized to represent cumula-
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FIG. 3. LAT does not activate the CMV promoter. (A) CV-1 and neuro-2A cells were transfected with pCMV cat (2 mg) and the indicated
amounts of plasmid pEV (Fig. 1). Blank expression vector (pNEB193) was used to maintain the same amounts of plasmid for each transfection.
At 48 h after transfection, CAT enzymatic activity was measured as described previously (13, 14, 28). The percent acetylated chloramphenicol
(%Ac-CM) was quantified using a PhosphoImager. (B) CV-1 cells were cotransfected with pCMV–b-Gal (1 mg of DNA) and pNEB193 (4 mg of
DNA) or pEV (4 mg of DNA). Some cultures were treated with etoposide (15 mM) at 16 h after transfection to induce apoptosis. At 48 h after
transfection, cells were stained to detect b-Gal1 cells. Representative panels are shown.
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FIG. 4. LAT interferes with Bax-induced apoptosis. (A) CV-1 cells were cotransfected with the designated LAT construct or a CMV expression
vector containing Bcl-2 (2, 4, or 8 mg of DNA), Bax (2 mg of DNA), and pCMV–b-Gal (1 mg of DNA). To maintain constant amounts of DNA,
a blank expression vector (pcDNA3.1) was added to the mixture. At 48 h after transfection, the number of b-Gal1 cells was counted. The number
of b-Gal1 cells present in control cultures (1 mg of pCMV–b-Gal and 9 mg of pcDNA3.1) was set at 100%. The values are the means of four
different experiments. (B to E) After b-Gal staining, cellular DNA was stained with Hoescht 3342 as described previously (13). b-Gal1 cells were
identified using phase contrast microscopy, and DNA staining of the same cell was visualized by fluorescence. Arrows denote b-Gal1 cells. (B)
CV-1 cells transfected with Bax (2 mg of DNA). (C) CV-1 cells transfected with a blank expression vector, pcDNA3.1. (D) CV-1 cells transfected
with Bax (2 mg of DNA) and APALAT (8 mg of DNA). (E) CV-1 cells transfected with Bax (2 mg of DNA) and pEV (8 mg of DNA). For panels
B to E, pCMV–b-Gal (1 mg of DNA) was included in each transfection. A blank expression vector (pcDNA3.1) was added to the mixture to
maintain the same amount of DNA (8 mg of DNA for each sample). An asterisk denotes an apoptotic cell, as judged by the presence of condensed
chromatin and apoptotic bodies.
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FIG. 5. Structures of LAT mutant viruses. (A) Schematic representation of wild-type HSV-1 and marker-rescued dLAT2903R. The prototypic
orientation of HSV-1 shown here contains a unique long (UL) region and a unique short (US) region (solid lines), each bounded by inverted repeats
(open rectangles). TRL, long terminal repeat; IRL, long internal repeat; TRS, short terminal repeat; IRS, short internal repeat. The dashed lines
under the genome indicate a blow up of the repeat regions. Arrows indicate the locations and directions of the LAT, ICP34.5, and ICP0 transcripts.
The solid rectangle within the primary 8.3-kb LAT transcript indicates the location of the stable 2-kb LAT intron. TATA indicates the location
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tive positive cultures per eye. The cumulative spontaneous
reactivation rate in rabbits latently infected with LAT1.8A
(Fig. 6A, approximately one positive culture per eye on day 26)
appeared to be less than that in rabbits infected with
dLAT2903R or LAT3.3A (Fig. 6A, approximately 3 to 3.5 per
eye on day 26) and similar to that in rabbits infected with
dLAT2903 (Fig. 6A, approximately 1 per eye). Similarly, cu-
mulative spontaneous reactivation of LAT2.5A appeared to be
less than that of LAT3.3A, which has wild-type spontaneous
reactivation (45), and similar to that of dLAT2903 (Fig. 6B).
In the first experiment, the number of positive eye cultures
(Table 1) indicated that only 3% of the tear film cultures from
rabbits latently infected with LAT1.8A contained spontane-
ously reactivated virus. This was similar to the number with
dLAT2903 (3.6%) but significantly less than that with
dLAT2903R (13.7%) and LAT3.3A (12.2%) (Table 1). In the
second experiment, only 0.6% of the tear film cultures from
rabbits latently infected with LAT2.5A contained spontane-
ously reactivated virus (Table 1). This was similar to the num-
ber with dLAT2903 (0.4%) and significantly less than that with
LAT3.3A (6%) in this experiment (Table 1). Because the
above analyses do not take into account the number of eyes in
each of the groups, the data were also analyzed as follows. The
percentage of days on which virus-positive cultures were ob-
tained for each eye in each group (i.e., the percentage of time
that each eye was positive for spontaneous reactivation) was
calculated, plotted as scattergrams, and analyzed by analysis of
variance (ANOVA) (Fig. 7). This is a very powerful and strin-
gent analysis because it takes into account both the number of
eyes in each group and the duration of the study in one cal-
culation. By this analysis, LAT1.8A reactivated similarly to
dLAT2903 but less efficiently than dLAT2903R and LAT3.3A
(Fig. 7A). This analysis also confirmed that LAT2.5A reacti-
vated similarly to dLAT2903 but less efficiently than LAT3.3A
(Fig. 7B). Thus, mutant viruses capable of expressing just the
first 76 or 661 nucleotides of LAT from the LAT promoter had
impaired spontaneous reactivation similar to the LAT null
mutant. This correlates with the inability of these same LAT
regions to promote cell survival after apoptosis in tissue cul-
ture, as described above.
In the experiments shown in Fig. 7 and Table 1, the spon-
taneous reactivation rates of the wild-type viruses LAT3.3A
and dLAT2903R (Fig. 7A) are higher than that of the wild-
type virus LAT3.3A (Fig. 7B). This type of variation between
experiments is common and is believed to be due to undeter-
mined environmental factors (unpublished observations).
(in the genomic DNA) of the LAT promoter TATA box. (B) Previously described LAT deletion mutant dLAT2903 (44), which contains a 1.8-kb
deletion (2161 to 11667) in both copies of the LAT gene (one in each long repeat), indicated by XXXX, makes no LAT RNA, and reactivates
poorly. (C) Mutant LAT3.3A, which was previously designated LAT1.5a (45). A blow up shows the 1.8-kb LAT promoter and the first 1.5 kb of
the LAT transcript inserted between genes UL37 and UL38 in the unique long region of the LAT deletion mutant dLAT2903. LAT3.3A transcribes
only the first 1.5 kb of LAT yet has wild-type spontaneous reactivation. (D, E, and F) LAT2.6A (16), LAT2.5A, and LAT1.8A, respectively,
containing the LAT promoter and the first 811 nucleotides of the LAT transcript, the LAT promoter and the first 661 nucleotides of LAT, and
the LAT promoter alone (up to LAT nucleotide 176), respectively, inserted between UL37 and UL38 of dLAT2903. LAT2.6A has a spontaneous
reactivation midway between that of the wild type and dLAT2903 (16). LAT2.5A and LAT1.8A are described here for the first time and have
spontaneous reactivation rates similar to that of dLAT2903.
FIG. 6. Cumulative spontaneous reactivation of LAT2.5A and LAT1.8A. Rabbits were ocularly infected with dLAT2903, dLAT2903R,
LAT3.3A, LAT1.8A, or LAT2.5A. Beginning on day 30 postinfection (p.i.) (day 1 of tear film collection), at which time latency had been
established, tear films were collected daily for 26 days. These samples were then plated on RS cell monolayers and observed for the presence of
CPE, which is indicative of spontaneously reactivated virus in the tears. Positive cultures were passaged, and DNA was analyzed. Southern analysis
confirmed that the CPE was due to HSV-1 and that the mutant spontaneously reactivated viruses retained their deletions. The y axis represents
the cumulative number of HSV-1-positive cultures for each virus group divided by the number of eyes in the group. Panels A and B show results
from separate experiments. Statistical analyses are shown in Table 1.
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However, within a single experiment, the relative spontaneous
reactivation rates between wild-type and LAT2 viruses always
remained similar. This illustrates the importance of including
wild-type and LAT2 control viruses in each experiment and of
housing all rabbits in each experiment in the same room.
DISCUSSION
The first 1.5 kb of the primary LAT (LAT3.3A) is sufficient
to restore wild-type levels of spontaneous reactivation to a
LAT null mutant (45). We show in this study that expression of
the same fragment in a plasmid (pLAT3.3) promotes cell sur-
vival after apoptosis induction. The first 811 nucleotides of the
primary LAT (LAT2.6A) only partially restore spontaneous
reactivation to a LAT null mutant (16). We showed here that
this LAT region (pLAT2.6) similarly only partially promoted
cell survival after apoptosis induction. Further deletion of the
LAT region (LAT2.5A and LAT1.8A) did not allow sponta-
neous reactivation or cell survival (pLAT2.5 and pLAT1.8).
Thus, the results presented here show a correlation between
the region of LAT capable of enhancing spontaneous reacti-
vation in rabbits and the region of LAT capable of promoting
cell survival after induction of apoptosis by chemicals or Bax. It
should be pointed out that LAT’s ability to inhibit apoptosis
could enhance spontaneous reactivation by at least two distinct
mechanisms. First, LAT could enhance spontaneous reactiva-
tion at the level of establishment or maintenance by enhancing
neuronal survival during acute infection. The finding that a
LAT null mutant (dLAT2903) has higher levels of apoptosis in
TG during acute infection than LAT1 strains (42) supports a
role for LAT in maximizing the number of neurons that survive
acute infection. Second, it is also possible that LAT directly
stimulates reactivation by prolonging survival of neurons as
well as nonneuronal cells during spontaneous reactivation,
thus maximizing virus production. Although the studies pre-
sented here correlate enhancement of cell survival with the
ability of LAT to promote spontaneous reactivation in latently
infected rabbits, they do not exclude the possibility that LAT
has additional functions that are necessary for lifelong latency
in humans.
Neuro-2A and CV-1 cells were used for these studies be-
cause we previously found that LAT had a positive effect on
cell survival in these cell lines. Since there is a correlation
between LAT’s inhibiting apoptosis in these cell lines and
promoting spontaneous reactivation in rabbits, there appears
to be biological relevance to the findings that we observed in
CV-1 and neuro-2A cells. In contrast, LAT had no effect on
cell survival in two transformed cell lines, 293 (human epithe-
lial cells immortalized by adenovirus) and COS-7 (CV-1 cells
transformed by simian virus 40) (data not shown). These vi-
ruses encode oncogenes that interfere with the growth-sup-
pressing properties of p53 and retinoblastoma protein and
impair the proapoptotic functions of p53. In general, expres-
sion of these viral oncogenes confers resistance to apoptosis.
We found that when a chemical agent was able to overcome
these dominant antiapoptotic viral oncogenes and induce apo-
ptosis in 293 and COS-7 cells, LAT was not able to promote
survival.
Interestingly, in CV-1 and neuro-2A cells, the same chemi-
cals had different effects on cell death. For example, etoposide
did not effectively kill CV-1 cells but did induce apoptosis in
neuro-2A cells. Furthermore, ceramide effectively induced apo-
ptosis in CV-1 cells (9, 10, 42) but not in neuro-2A cells (data
not shown). Several different apoptotic pathways are regulated
TABLE 1. Spontaneous reactivation
Expt Virus No. of positive cultures/no. tested (% positive)
Significance vs.
control (P)
1 LAT1.8A (control) 14/468 (3.0)
dLAT2903 13/364 (3.6) 0.70
dLAT2903R 50/364 (13.7) ,0.0001
LAT3.3A 38/312 (12.2) ,0.0001
2 LAT2.5A (control) 6/1,092 (0.6)
dLAT2903 3/780 (0.4) 0.74
LAT3.3A 62/1,040 (6.0) ,0.0001
FIG. 7. Scattergram representation of spontaneous reactivation. Each data point represents the percentage of days during the 26-day obser-
vation period on which individual eyes were positive for spontaneously reactivated virus. To visually separate the individual data points, some of
the zero points are plotted slightly below zero. The P values (ANOVA, Tukey post test) in panel A are relative to LAT1.8A. The P values in panel
B are relative to LAT2.5A. dLAT, dLAT2903; dLATR, dLAT2903R.
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by numerous factors. During immortalization or transforma-
tion of mammalian cells, the apoptotic pathways may be al-
tered, resulting in the generation of long-lived cell lines that
grow continuously. Thus, it is difficult to make sweeping con-
clusions about the ability of LAT to interfere with cell death
induced by Bax or the chemicals used in this study. In spite of
these shortcomings, one can conclude that LAT has the po-
tential to inhibit cell death, which is consistent with previous
findings (42). In particular, LAT can interfere with Bax-in-
duced apoptosis in CV-1 cells.
Because the stable 2-kb LAT is easily detected during neu-
ronal latency while the remaining LAT RNA is difficult to
detect, the term LAT is sometimes used to refer to the 2-kb
LAT rather than the primary 8.3-kb transcript. We showed
here that a plasmid expressing the first 1.5 kb of the primary
8.3-kb LAT promotes cell survival as efficiently as a plasmid
expressing the entire 2-kb LAT. This 1.5-kb region contains
only the first 838 nucleotides of the 2-kb LAT, and none of this
RNA has the stability of the intact 2-kb LAT (45). Thus, as we
showed previously for spontaneous reactivation (45), neither
the entire 2-kb LAT nor stability of the LAT RNA is required
for promoting cell survival after apoptosis induction.
Although the 1.5-kb transcript contains several small open
reading frames (ORFs), they are not well conserved among
HSV strains KOS, McKrae, and 17syn1, even though LATs
from all three of these strains can promote efficient spontane-
ous reactivation (15). This suggests that these ORFs are not
expressed or not important or that their functional domains
are small and not very obvious. The lack of an obvious poly(A)
addition site in the pLAT3.3 plasmid, which nonetheless pro-
moted cell survival, and the lack of obvious poly(A) addition
sites within the insertion site in the LAT3.3A virus, which
nonetheless reactivates efficiently from latency, appear to sup-
port the hypothesis that a LAT protein is not expressed. If a
LAT protein does not exist, it would appear that LAT RNA
sequences promote cell survival.
Approximately 90% of steady-state LAT (i.e., the stable
2-kb LAT) is localized in the nucleus (50, 56). Only 10% of
LAT is found in the cytoplasm, some of which appears to be
associated with polyribosomes (24). At first glance, this ap-
pears to be inconsistent with the ability of LAT to block apo-
ptosis, as this function might be thought of as requiring a LAT
product in the cytoplasm. Even if LAT were exclusively limited
to the nucleus, it could inhibit apoptosis by regulating tran-
scription of one or more cellular genes. The stable 2-kb LAT
represents the overwhelming majority of LAT that is detected
during acute and latent infection, suggesting that if other novel
forms of LAT were expressed, they would be difficult to detect.
Thus, studies indicating that LAT is localized in the nucleus
are essentially referring to the 2-kb LAT. As discussed above,
the stable 2-kb LAT is not required either for wild-type levels
of spontaneous reactivation or for blocking apoptosis. These
functions can both be accomplished by just the first 1.5 kb of
the primary LAT, a fragment that includes only the first 838
nucleotides of the 2-kb LAT. This truncated LAT lacks the
stability of the 2-kb LAT, and its subcellular location is un-
known. Thus, it will be of interest to elucidate the structure and
subcellular localization of transcripts that are expressed by
LAT sequences which are capable of inhibiting apoptosis.
Studies directed at pinpointing the sequences in LAT that
interfere with apoptosis and identification of cellular compo-
nents affected by LAT will be pursued.
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